Telsey Advisory lowered the firm's price target on Zevia to $3 from $5 and keeps an Outperform rating on the shares. The company reported better-than-expected Q1 results, which reflect strong volume gains of 20.4%, the analyst tells investors in a research note. The firm believes Zevia continues to make progress on its turnaround based on higher 2026 sales growth guidance, though the company lowered its FY26 adjusted EBITDDA guidance due to higher-than-anticipated tariffs and fuel costst.
